Ivan BERGO 1,2, David ECKERT 1,2, Amalia PUȘCAȘ 1, George JÎTCĂ 1*, Amelia TERO-VESCAN 1
1 Department of Biochemistry, George Emil Palade University of Medicine, Pharmacy, Science Technology of Târgu Mureș, Romania
2 Department of Biochemistry, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania, Campus Hamburg - UMCH, Hamburg, Germany
1 Department of Biochemistry, George Emil Palade University of Medicine, Pharmacy, Science Technology of Târgu Mureș, Romania
2 Department of Biochemistry, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania, Campus Hamburg - UMCH, Hamburg, Germany
Polycystic Ovarian Syndrome (PCOS) is a disease that is characterized by an increased Gonadotropin-Releasing-Hormone (GnRH) pulsatile frequency, causing an altered LH/FSH ratio. More precisely an increased Luteinizing Hormone (LH) secretion compared to a decreased Follicle-Stimulating Hormone (FSH) secretion leads to the development of hyperandrogenism and to a low-level concentration of estrogens and therefore decreased negative estrogenic feedback in the control axis. The purpose of this review is to connect the physiological Hypothalamic-Pituitary-Ovarian (HPO) axis with said pathology and the ensuring discussion about the possible mechanisms of pathogenesis and guidelines for relieving associated symptoms.